{"disease":{"id":"nephroid-carcinoma","name":"nephroid carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00719264","title":"Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}